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Abstract
Students of a university hospital were assessed in 2007 and later in 2013 to determine the prevalence of metabolic
syndrome. Statistical analysis was done with SPSS version 17.0.
A total of 213 students were evaluated in both 2007 and 2013 (48.3 % women and 51.7 % men). The diagnosis of
overweight and obesity increased from 24.9 to 37.1 % (p < 0.05), central obesity from 17.8 to 28.6 % (p < 0.05), and
prevalence of metabolic syndrome from 9.8 to 14.5 % (p ≥ 0.05); up to 20 % in male gender. It is important to
implement programs for early diagnosis of metabolic syndrome.
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Metabolic syndrome is a group of vascular and
metabolic risk factors, including insulin resistance,
dyslipidemia and hypertension [1–4]. Cardiovascular
disease is its primary clinical outcome and it is esti-
mated that people with this condition have a 3-fold
higher risk for an acute coronary syndrome or a cere-
bral vascular event; also the risk of mortality is 2
times higher [5]. Other diseases related to metabolic
syndrome are type 2 diabetes mellitus, polycystic
ovary syndrome, fatty liver, asthma, sleep disorders,
and cancer [6].
Some studies show that young adults who enter school
have poor health habits (lack of physical activity, tobacco
and alcohol use, and unhealthy diet). Additionally, it has
been noted that first-year students gain weight faster
than the average adult [7–10]. Morrison et al. noted that
the diagnosis of metabolic syndrome in infancy, predicts
cardiovascular disease 25 years later [11]. The prevalence
of metabolic syndrome in students according to the lit-
erature varies from 1.3 to 14.3 % [12–16].
The aim of this study is to evaluate the change in the
prevalence of metabolic syndrome in a population of
medical students over a six-year period using the defin-
ition of the International Diabetes Federation.
Research design and methods
We performed a prospective, descriptive and non-
randomized study in freshmen medical students from
the Faculty of Medicine registered in August 2007
(under 20 years of age) and that remained registered in
August 2013 (under 30 years of age), in a University
Hospital. Pregnant subjects were excluded. The study
design was approved by the institution’s ethics commit-
tee and informed consent was obtained from all the par-
ticipants. On enrollment day, students who accepted to
participate in the study, anthropometric measurements
were taken, blood samples to perform blood chemistry
and lipid profile were drawn, and blood pressure was
measured.
To determine metabolic syndrome, International
Diabetes Federation criteria were used. Abdominal
obesity was defined as a waist circumference ≥ 90 cm in
men and ≥ 80 cm in women, plus two of the following:
fasting plasma glucose greater than 100 mg/dL or a prior
diagnosis of DM2, triglycerides ≥ 150 mg/dL, HDL
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cholesterol ≤ 40 mg/dL in men or ≤ 50 mg/dL in women,
and a systolic blood pressure ≥ 130 mmHg or a diastolic
blood pressure ≥ 85 mmHg.
Economic status, hometown and parents job were not
evaluated in this study population.
Results
Two thousand thirteen students were included in the
study: 48.3 % women and 51.7 % men. Demographic and
laboratory characteristics of the population are shown in
Tables 1, 2 and 3.
The mean BMI at baseline was 22.98 kg/m2, while at
the end it was 24.37 kg/m2 (p < 0.05), with the male
population showing a BMI in the range of overweight
(25.10 kg/m2). The number of students with overweight
and obesity increased from 24.9 to 37.1 % (p < 0.05).
However, this increase was only statistically significant
among men, the group in which mean weight gain after
6 years was about 6 kg.
The diagnosis of central obesity increased from 17.8 to
28.6 % (p < 0.05), and by gender it was only significant
among women (12.6 vs 24.3 %). The components of
metabolic syndrome in 2007 in order of importance
were low HDL cholesterol (59.1 %), hypertriglyceridemia
(38.1 %), hyperglycemia (25.8 %), and hypertension
(13.6 %), while in 2013 HDL cholesterol remained as the
most important factor (67.1 %), followed by hyperten-
sion (33.8 %), abdominal obesity (28.6 %), hyperglycemia
(10.3 %) and hypertriglyceridemia (5.6 %). It is important
to note that at the start of the study, a higher prevalence
of low HDL cholesterol in women (66.9 51.8 %) was iden-
tified, which denoted statistical significance (p < 0.05).
Hypertension prevalence increased significantly only in
the male population. Both hypertriglyceridemia and
hyperglycemia showed a decreasing trend with statistical
significance (p < 0.05) throughout the study.
Based on the definition of the IDF, in 2007, metabolic
syndrome was diagnosed in 9.8 % of the population,
while in 2013, it was in 14.5 %. This did not represent a
significant change (p ≥ 0.05) in the general population
neither by gender.
Our study has important findings: most participants had
at least one component of the metabolic syndrome (69.2 %
in 2007 and 76.4 % in 2013); low HDL cholesterol is the
Table 1 Anthropometric, clinical and biochemical characteristics
of the total population
Variable Total population (n = 213) p
2007 2013
Age (years) 17.27 (1.11) 23.26 (1.09) <0.05
Weight (kg) 63.71 (13.93) 68.41 (14.57) <0.05
BMI (kg/m2) 22.98 (4.09) 24.37 (4.04) <0.05
Waist (cm) 76.27 (11.02) 80.75 (10.79) <0.05
Systolic BP (mm Hg) 115.51 (11.70) 119.61 (15.18) <0.05
Diastolic BP (mm Hg) 73.11 (8.08) 73.44 (10.10) ≥0.05
Glucose (mg/dL) 87.69 (24.37) 84.86 (12.66) ≥0.05
Triglycerides (mg/dL) 146.93 (77.13) 81.85 (43.81) <0.05
HDL Cholesterol (mg/dL) 42.97 (12.27) 40.23 (12.37) <0.05
LDL Cholesterol (mg/dL) 114.30 (56.01) 95.71 (34.81) <0.05
Total Cholesterol (mg/dL) 184.95 (61.71) 151.73 (35.38) <0.05
Data are shown as Mean ± standard deviation
BMI body mass index; BP blood pressure; LDL low-density lipoprotein cholesterol;
HDL high-density lipoprotein cholesterol. Student’s t test was used for the analysis
with a p <0.05 being considered statistically significant
Table 2 Anthropometric, clinical and biochemistry
characteristics of the female population
Variable Women (n = 103) p
2007 2013
Age (years) 17.02 (1.03) 23.1 (1.04) <0.05
Wight (kg) 56.43 (10.66) 59.98 (11.65) <0.05
BMI (kg/m2) 22.42 (3.90) 23.58 (4.23) <0.05
Waist (cm) 71.11 (9.19) 75.08 (9.62) <0.05
Systolic BP (mm Hg) 114.3 (11.69) 110.6 (11.3) ≥0.05
Diastolic BP (mm Hg) 72.09 (7.55) 70.35 (9.07) <0.05
Glucose (mg/dL) 87.93 (24.85) 83.45 (12.70) ≥0.05
Triglycerides (mg/dL) 132.34 (60.21) 70.12 (24.13) <0.05
HDL Cholesterol (mg/dL) 44.27 (11.93) 43.29 (13.09) ≥0.05
LDL Cholesterol (mg/dL) 122.07 (58.89) 94.44 (37.33) <0.05
Total Cholesterol (mg/dL) 190.98 (67.70) 150.88 (38.73) <0.05
Data are shown as mean ± standard deviation
BMI body mass index; BP blood pressure; LDL low-density lipoprotein cholesterol;
HDL high-density lipoprotein cholesterol. Student’s t test was used for the analysis
with a p <0.05 being considered statistically significant
Table 3 Anthropometric, clinical and biochemistry
characteristics of the male population
Variable Men (n = 110) p
2007 2013
Age (years) 17.53 (1.04) 23.44 (1.16) <0.05
Wight (kg) 70.53 (13.20) 76.31 (12.49) <0.05
BMI (kg/m2) 23.50 (4.21) 25.10 (3.73) <0.05
Waist (cm) 81.12 (10.42) 86.06 (9.01) <0.05
Systolic BP (mm Hg) 116.63 (11.65) 128.08 (12.83) <0.05
Diastolic BP (mm Hg) 73.36 (8.57) 76.33 (10.21) <0.05
Glucose (mg/dL) 87.46 (24.02) 86.21 (12.53) ≥0.05
Triglycerides (mg/dL) 160.58 (88.26) 92.64 (54.27) <0.05
HDL Cholesterol (mg/dL) 41.79 (12.51) 37.42 (11.01) <0.05
LDL Cholesterol (mg/dL) 107.17 (52.47) 96.87 (32.46) ≥0.05
Total Cholesterol (mg/dL) 179.31 (55.23) 152.56 (32.08) <0.05
Data are shown as mean ± standard deviation
BMI body mass index; BP blood pressure; LDL low-density lipoprotein cholesterol;
HDL high-density lipoprotein cholesterol. Student’s t test was used for the analysis
with a p <0.05 being considered statistically significant
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most prevalent risk factor; and the male population had
more marked metabolic abnormalities.
Conclusions
The change in the prevalence of metabolic syndrome
among our student population was not statistically sig-
nificant. Low HDL cholesterol and hypertriglyceridemia
were the main risks factors in the population less than
20 years of age, while in the population of 20–30 years,
low HDL cholesterol and high blood pressure were the
main risk factors (low HDL cholesterol affected two
thirds of the population). Therefore, it is important the
study of young populations in order to make a timely
intervention in individuals at risk, given the high preva-
lence of metabolic abnormalities at an early age.
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